SCHEMBL7491703

SCHEMBL7491703

O=S(=O)(Oc1ncc2ccccc2n1)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALPL P05186 1/20 0.38
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ PDE4A P27815 3/20 0.35
▸ PDE4C Q08493 3/20 0.35
▸ PDE4D Q08499 3/20 0.35
▸ CYSLTR2 Q9NS75 1/20 0.35
▸ CYSLTR1 Q9Y271 1/20 0.35
▸ SLC22A12 Q96S37 1/20 0.34
▸ ADRA2A P08913 1/20 0.33
▸ NPY5R Q15761 1/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GPR3 P46089 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ FDPS P14324 1/20 0.32
▸ DRD2 P14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16225036 0.76 PDE4A (0.34) CA1CA2PDE4APDE4CPDE4D
SCHEMBL2708721 0.75 ALPL (0.49) ALPLCA1CA2SLC22A12CYP1A2
SCHEMBL4753618 0.75 ALPL (0.39) ALPLADRA2ANPY5RMCHR1KDM4E
SCHEMBL30904613 0.75 ALPL (0.39) ALPLADRA2ANPY5RMCHR1KDM4E
SCHEMBL29461538 0.74 MGAM (0.40) CA1CA2PDE4APDE4CPDE4D
SCHEMBL244946 0.74 MGAM (0.40) CA1CA2PDE4APDE4CPDE4D
SCHEMBL15110631 0.73 HTT (0.51) ALPLKDM4ECYP1A2ALDH1A1LMNA
SCHEMBL127875 0.73 PDE4A (0.46) ALPLCA1CA2PDE4APDE4C
SCHEMBL30808338 0.72 LMNA (0.42) CYSLTR2CYSLTR1KDM4EGPR3EGFR
SCHEMBL6614036 0.72 CNR2 (0.35) KDM4EGPR3EGFRCYP1A2FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218354-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS AstraZeneca AB (SE) 2002-07-03 — — EP disclosed
WO-2001021596-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRAZENECA AB (SE) 2001-03-29 — — WO disclosed
Send feedback